BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12556973)

  • 1. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.
    Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I
    Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
    Owen LA; Kowalewski AA; Lessnick SL
    PLoS One; 2008 Apr; 3(4):e1965. PubMed ID: 18414662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
    May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
    Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous partnerships in Ewing's sarcoma.
    Sankar S; Lessnick SL
    Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
    Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
    Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
    Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
    Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
    Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
    Gangwal K; Lessnick SL
    Cell Cycle; 2008 Oct; 7(20):3127-32. PubMed ID: 18927503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
    Mao X; Miesfeldt S; Yang H; Leiden JM; Thompson CB
    J Biol Chem; 1994 Jul; 269(27):18216-22. PubMed ID: 7517940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWS/Fli-1 chimeric protein is a transcriptional activator.
    Ohno T; Rao VN; Reddy ES
    Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
    Silvany RE; Eliazer S; Wolff NC; Ilaria RL
    Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.
    Braun BS; Frieden R; Lessnick SL; May WA; Denny CT
    Mol Cell Biol; 1995 Aug; 15(8):4623-30. PubMed ID: 7623854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
    Wiles ET; Lui-Sargent B; Bell R; Lessnick SL
    PLoS One; 2013; 8(3):e59369. PubMed ID: 23527175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRE elements are binding sites for the fusion protein EWS-FLI-1.
    Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
    Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.